[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 710500, "exercisedValue": 0, "unexercisedValue": 56986}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 416700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 54, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 44.57, "open": 41.665, "dayLow": 41.665, "dayHigh": 45.819, "regularMarketPreviousClose": 44.57, "regularMarketOpen": 41.665, "regularMarketDayLow": 41.665, "regularMarketDayHigh": 45.819, "payoutRatio": 0.0, "beta": 1.018, "forwardPE": -18.097458, "volume": 16156, "regularMarketVolume": 16156, "averageVolume": 41514, "averageVolume10days": 17360, "averageDailyVolume10Day": 17360, "bid": 0.0, "ask": 43.0, "bidSize": 0, "askSize": 1, "marketCap": 272438112, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 54.3, "fiftyDayAverage": 36.138, "twoHundredDayAverage": 20.448574, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 200856640, "profitMargins": 0.0, "floatShares": 3503249, "sharesOutstanding": 6112590, "sharesShort": 51820, "sharesShortPriorMonth": 51271, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0085, "heldPercentInsiders": 0.34519002, "heldPercentInstitutions": 0.42321, "shortRatio": 1.62, "shortPercentOfFloat": 0.0168, "impliedSharesOutstanding": 6378790, "bookValue": 9.019, "priceToBook": 4.735558, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15586419, "trailingEps": -4.11, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 12.141539, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 42.71, "targetHighPrice": 76.0, "targetLowPrice": 40.08, "targetMeanPrice": 58.69333, "targetMedianPrice": 60.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 60212200, "totalCashPerShare": 9.851, "totalDebt": 0, "quickRatio": 11.46, "currentRatio": 11.475, "returnOnAssets": -0.29869, "returnOnEquity": -0.5142, "freeCashflow": -5475820, "operatingCashflow": -6404139, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "regularMarketChangePercent": -4.173212, "regularMarketPrice": 42.71, "corporateActions": [], "postMarketTime": 1745620317, "regularMarketTime": 1745611202, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "postMarketChangePercent": -1.91992, "postMarketPrice": 41.89, "postMarketChange": -0.82, "regularMarketChange": -1.8600006, "regularMarketDayRange": "41.665 - 45.819", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 41514, "fiftyTwoWeekLowChange": 40.989998, "fiftyTwoWeekLowChangePercent": 23.831394, "fiftyTwoWeekRange": "1.72 - 54.3", "fiftyTwoWeekHighChange": -11.59, "fiftyTwoWeekHighChangePercent": -0.21344383, "fiftyTwoWeekChangePercent": 1214.1538, "earningsTimestamp": 1743422401, "earningsTimestampStart": 1746793800, "earningsTimestampEnd": 1747917000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.11, "epsForward": -2.36, "epsCurrentYear": -2.63333, "priceEpsCurrentYear": -16.219007, "fiftyDayAverageChange": 6.5719986, "fiftyDayAverageChangePercent": 0.18185839, "twoHundredDayAverageChange": 22.261425, "twoHundredDayAverageChangePercent": 1.0886542, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]